Assessing physician practices and expectations in the post-COVID era
The ongoing COVID-19 pandemic has affected the routines of many practicing physicians, including an impact on their prescribing decisions. New research from CRA shows that […]
Views and analysis
3 practical steps for improving patient support
Research Partnership’s Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to make their patient support programmes as powerful […]
Health literacy needs support, now more than ever
The COVID-19 pandemic has brought healthcare guidelines and scientific advances front-of-mind on a global scale, in the process highlighting long-standing gaps in health literacy as […]
Plugging modular content into pharma’s omnichannel strategies
86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a greater volume of content now, compared to […]
Unlocking the potential in rare disease research with decentralised trials
A survey by rare disease patient network Raremark found that 86% of the community members asked were interested in taking part in clinical trials. CEO […]
Pharma digital transformation: customer data expected to play a pivotal role
A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets. […]
The elective care conundrum – can digital innovation help?
Karina Malhotra from Acumentice explores how digital tech and data could help address the NHS elective care backlog in 2021 and beyond. The repercussions of […]
A collaborative approach to greater diversity in clinical trials
The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades. Despite the […]
A new approach to COVID-19 treatment
While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus. CEO Dr. Jonathan Javitt tells […]
GSK’s Neale Belson on building trust with employees and society
Pharma’s reputation is currently riding high as the industry comes together to tackle COVID-19, but GSK’s UK general manager Neale Belson says there is always […]
Enabling new models of care: pursuing pharma’s partnership potential
There is a huge, ongoing shift in how health and wellness is approached in the UK, and the changes will have important implications for NHS-industry […]
Nine for 2021: Addressing the pandemic legacy
In this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact pharma in 2021: the permanent changes in […]
Coordinating and delivering research in the pandemic: The UK approach
The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure […]
Are face-to-face medical meetings a thing of the past?
Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception. In their droves, congresses, conferences, and masterclasses […]
‘No going back’ for clinical trials after COVID
Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result. The next step is ensuring […]
2021 – UK market access prospects
With a new year comes the opportunity to think ahead for the market access landscape for the coming year. 2020 was a big year for […]
2021 – The healthcare changes here to stay
2020 was the year that changed everything, and as the new year begins many are wondering what awaits the world in 2021. Impetus Digital co-founder […]
How patient insights are changing trial solutions
Patients have been asking for patient-centric trial solutions for years – the industry just hasn’t been listening. That’s according to Medidata’s Anthony Costello, who was […]
COVID-19 and the digital pharma marketing revolution
The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Once the […]
Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy
As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine […]
True patient-focused research through decentralised and hybrid trials
How can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector give their thoughts on the key approaches […]
2021 Outlook: The future for life sciences customer experience
Research from a large-scale survey of 1000+ senior pharma professionals has highlighted the divide between digitally adept companies and those that have been slow to […]
Why cell therapy manufacture is a team sport
Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that sits behind the process of individualised cell […]
Boosting the impact of patient services
New research from Accenture has revealed that adoption of patient support services hasn’t improved since 2015 despite increasing pharma investment. The company’s Jennifer Spada tells […]
The Alderley Park Discovery Podcast: Life science skills, staffing and support
Episode two of the Alderley Park Discovery Podcast covers access to skills in the life sciences sector, with a focus on support for aspiring scientists […]
Nine for 2021: The COVID-19 legacy
In the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that will affect the global healthcare and pharmaceutical […]
How Big Data will accelerate the future of digital medicine in 2021
The pandemic has shed light on inefficiencies in healthcare systems, and provided an opportunity to adjust how we manage care in the future. Jennifer Haas, […]
5 ways digital health, and digital pharma, changed in 2020
Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, any definitive ‘coming of age’ moment for […]
J&J and medical device innovation: the pharmaphorum podcast
In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU regional vice president at J&J Surgical Vision. She talks about her […]
2020 in review: COVID-19 and patient centric clinical trials
The trials and tribulations of 2020 have brought the vital role of research, pharma, and biotech into sharp focus. But how has the push to […]
Moderna and BioNTech – who are they?
Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these […]
The top 5 pharma M&A deals of 2020
2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan […]
Finding agility in unprecedented times
Nicole Farmer, general manager, UK & Ireland at Sanofi Genzyme, tells us how the company aimed for agile adaptation during COVID-19, and how these lessons […]
Health inequalities: A societal challenge that needs a cross-sector solution
COVID-19 has laid the UK’s health inequalities bare and created an imperative for the NHS to develop a step-change in how it cares for diverse […]
Patient journeys in the era of COVID-19
OPEN Health’s Richard Jones and Sumira Riaz assess the pandemic’s implications for understanding patients’ experiences and how the pharma industry can support them It’s impossible […]
Tay-Sachs and rare disease registries – the Health Heroes podcast
Episode four of Kantar Health’s Health Heroes podcast tackles pharma’s rare disease challenges, the role of patient registries and hears a moving story about the […]
How pharma needs to change for the era of digital health
Experts from Healthware Group explore how companies can rebuild their approach to digital from the ground up for the benefit of patients. Digital is not […]
The critical role of the generics sector during the pandemic
Graeme Duncan from ADVANZ PHARMA explores how successful cross-industry collaboration between pharma and generics companies has helped support supply challenges during the pandemic. While the […]
Deep Dive: Patients and Partnerships
As this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – it requires companies to truly listen to, […]
Have you checked your brand’s temperature?
In today’s fast-paced world how do you make sure your brand messages resonate with your customers and, if they do, how can your brand become […]
Does a lack of diversity in clinical trials reflect a lack of diversity among researchers?
Embedding diversity into clinical research does not start and end at trial recruitment – the community needs processes and institutions that reflect society and provide […]
An introduction to the new NIHR National Patient Recruitment Centres
A new network of patient recruitment centres is set to shape the future of commercial clinical trials in the UK by offering new approaches to […]
What HCPs think about COVID-19’s impact on cancer
COVID-19’s knock-on effect on cancer patients is of concern by HCPs, with delayed or decreased diagnosis seen as a key worry. CREATION.co’s Lara Meyer explores […]
Sharing experiences to level the healthcare playing field
Amanda Barrell speaks to Alfred Samuels on his experience of prostate cancer and diversifying clinical trials to include the Black, Asian and minority ethnic (BAME) […]
Latin America: How pharma can navigate a complex market
Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and […]
The urgent need for education and awareness about mitochondrial disease
Delayed diagnosis, misdiagnosis, and no cure or disease modifying treatments – children living with mitochondrial disease face all the issues often associated with rare diseases. […]
Are pharma’s TV ad strategies out of date?
TV viewing habits are changing dramatically, and these trends have only been accelerated by COVID-19 – but Intouch’s Justin Chase says that pharma is still […]
A history of Pfizer
Few companies embody the term ‘pharma giant’ as much as Pfizer. Here we take a look at the colourful history of one of the biggest […]
VR, COVID and ensuring safety with cutting-edge tech
Not too long ago virtual reality (VR) tech might have seemed like a dream, but now it’s being harnessed by the healthcare industry for a […]
Healthcare that no longer leaves out the patient
For so long the US healthcare system was built around the provider, with appointments and services set by the provider (along with insurance reimbursement systems). […]
‘Knowledge is power’ for rare diseases and NAbs
Cure Rare Disease’s Rich Horgan discusses the importance of preclinical NAbs screening and helping rare disease patients better understand their eligibility for gene therapies. Neutralising […]
Navigating the NHS as a digital start-up
We speak to finalists from the Greater Manchester Future of Health accelerator to find out how digital start-ups can overcome the challenges small companies face […]
How the rare disease community has developed fertile ground for progress
Amanda Barrell explores how a perfect storm of changing economics, advances in technology, and the increasing volume of the patient voice is stoking change in […]
COVID-19 lessons for how pharma should support patient advocacy
Trio Health’s Neil McGregor-Paterson asks whether the healthcare industry has paid enough attention to the patient voice during COVID-19 and looks at the many ways […]
A pivotal moment for digital health adoption
Former chief digital officer for the NHS, Juliet Bauer, is now applying her experience to the private sector through video consultation firm Livi. She shares […]
Digitally engaging doctors around the world
Pharmaceutical marketing budgets are going through a period of readjustment as companies explore and exploit a myriad of different digital channels to deliver content to, […]
Healthcare’s COVID-19 backlog: how pharma can help
IQVIA’s Sarah Rickwood explores how pharma can help healthcare systems address treatment backlogs caused by the COVID-19 pandemic. As lockdowns started in the West during […]
3 steps for comprehensive patient collaboration
Janssen’s Daniel de Schryver tells us why it’s time to give patients a permanent seat at the table and improve health outcomes through patient-pharma dialogue. […]
What will the digital health ecosystem look like post-COVID?
COVID-19 has turned the world on its head and healthcare systems have had to respond rapidly to match the sudden changes created by lockdown. Digital […]
Media means business
COVID-19 has left us more reliant on media than ever – both the pharma industry and society as a whole. Havas Lynx Group’s 2020 white […]
3 innovations booming during COVID and how to adopt them successfully
Research Partnership’s Vicki Newlove explores research into digital change during COVID-19 to find out what business questions pharma needs to address to succeed with innovations. […]
Pharma needs to adapt its communications or be left behind
As the world continues to grapple with the ongoing impact of coronavirus, the healthcare industry has taken centre-stage, working tirelessly and more collaboratively than ever […]
COVID-19: Helping to support momentum on antimicrobial innovation
To mark World Antimicrobial Awareness Week NovaBiotics’s Deborah O’Neil tells us why 2021 might be the year anti-infective drugs finally demonstrate their economic value. COVID-19 […]
Digital therapeutics: Why human psychology is key to adoption
The healthcare system is running at its limits in many countries worldwide. One reason is the growing demand for healthcare, largely driven by the rise […]
Vertex Pharma’s vision for reimbursement innovation
As regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s novel cystic fibrosis drug Kaftrio. He tells […]
Towards a new understanding of cardiovascular risk in diabetes
A new post-hoc analysis from Novo Nordisk of their SUSTAIN 6 and PIONEER 6 studies into semaglutide is looking to help ‘individualise’ treatment for diabetes […]
Bridging the gap between pharma and the NHS in MS
Janette Curlis is a Multiple Sclerosis Nurse Advisor (MSNA) at Biogen, helping to support the company’s Multiple Sclerosis (MS) field teams and developing patient and […]
Pharma brands must ‘up the ante’ in their digital presence
Since Covid-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance […]
Frontiers Health 2020 day two
It’s day two of digital health innovation conference Frontiers Health, which will be mainly held online because of the COVID-19 pandemic. This year Frontiers will […]
Building the infrastructure for successful digital health start-ups
2020 might go down as the year digital health truly began to boom – but to continue thriving, health tech start-ups will need a strong […]
Frontiers Health 2020 day one
Digital health innovation conference Frontiers Health kicks off its 2020 edition this week, although the majority of the conference will be held online because of […]
Health Innovators: David Van Sickle on digital innovation in respiratory medicine
In the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Propeller Health about how digital technologies are […]
AI implementation for pharma and healthcare
Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, and patient treatment. With AI already the […]
Two decades of digital: the changing habits of pharma and HCPs
When Chris Cooper of EPG Health launched his ‘European Prescriber Guide’ software twenty years ago, he was among a select few taking digital in pharma […]
Pharma’s response to COVID: Lilly and diabetes care
As part of our series looking at how pharma companies have adapted to the pandemic, Shannon Rush, leader of Eli Lilly & Co’s diabetes business […]
Germany’s digital health changes will boost digital therapeutics in Europe
Digital therapeutics are gaining momentum worldwide and offer developers, including pharma, both a huge opportunity and a stimulating market access challenge, say Olaf Schoeman and […]
Are rapid progress and patient engagement mutually exclusive in a COVID-19 world?
COVID-19 has sparked a flurry of research and discoveries are being made at an unprecedented rate – but patient participation cannot and should not be […]
A new dawn for clinical trial management
It’s time for pharma to take a 360-degree view of its clinical trial data and step into the future with near real-time trial management. The […]
Enabling innovation by connecting an ecosystem of partners
COVID-19 has been a shock to the system for every industry, not least pharma, but the sector is already looking at new ways to build […]
The key elements driving the success of digital health
Ahead of Frontiers Health 2020, steering committee members Roberto Ascione and Paul Tunnah from Healthware give us their thoughts on the trends driving the bright […]
Be in the room: Turning patient engagement to patient centricity
After three brushes with cancer, Robert Weker understands the patient journey more than many – and he is determined to put that experience to good […]
Ring 20: Could the rare disease get left behind by next-generation gene sequencing?
Ring Chromosome 20 Syndrome, or (R)20, is an ultra-rare form of epilepsy with a devastating impact – yet despite huge leaps forward in gene sequencing […]
AI’s infiltration of pharma: How COVID-19 accelerated change
The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement […]
Deep Dive: Digital Health Innovation 2020
Most of the digital health experts we spoke to for this issue of Deep Dive made one thing clear – no one can really say […]
GSK and eosinophil research: the pharmaphorum podcast
GlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Syndrome (HES). It’s part of the company’s […]
Ipsen’s UK MD on adapting business to COVID-19
Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has taken him across the business from Novartis, […]
NICE talking to you: Trends in early HTA engagement
With exclusive data from Freedom of Information (FOI) requests sent to the National Institute for Health and are Excellence (NICE), Leela Barham takes a look […]
Why 72% of patients don’t feel listened to by pharma
Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for […]
What can we learn from women’s health data?
Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised […]
Pharma 2030: Will payers fund more preventive care programmes?
Preventive care programmes are key to better health outcomes, but several factors are limiting their uptake. A new analysis looks at these barriers and asks […]
10 Tips for Digital Asset Management Success
Given the recent rise in digital engagement and the drastic increase in digital content, it’s now essential that pharmaceutical companies have a comprehensive content strategy. […]
Data hackathon analyses truth behind TB vaccine and COVID-19
Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing […]
Toxic positivity and grief: The reality of living through cancer
Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient advocate Megan-Claire Chase. No one gets through […]
What HCPs Think about schools reopening
In our latest article in the What HCPs Think series, CREATION.co’s Jamie Doggett analyses the social media activity of doctors to determine their views on […]
Time to change the channel? The future for customer engagement models
Sarah Rickwood delves into IQVIA data to find out exactly how pharma’s HCP engagement has changed over COVID-19, and what the channel mix might look […]
How real human experiences can power a healthier future
As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data […]
Rare diseases, repurposing and the role of AI
In the age of artificial intelligence, no trial data should be going to waste. Findacure’s Rick Thompson looks at how these technologies could bring us […]
Accelerating the digital approval process
The boom in digital tech over COVID means that pharma can move faster than ever – but the industry’s traditional processes for asset approval are […]
Flying the flag for research in Aarskog syndrome
Delayed diagnosis, lack of awareness, and a limited evidence base – Aarskog syndrome faces all the challenges of rare diseases everywhere. But a new study […]
Pharma’s response to COVID: GSK
A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping […]
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies. Value in healthcare is […]
Pharma’s digital transformation journey and the role of customer reference data
Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. pharmaphorum’s Richard Staines spoke to her about how the […]
Why intelligent automation is the future for regulation
There are a host of new, previously unimaginable tools and techniques – from analytics to robotic process automation (RPA) and artificial intelligence (AI) – available […]
The value of good data to patients
Better patient care pathways and models of care can be leveraged from the use of data, and the ability to collate and assess this information […]
The tools and techniques making virtual patient simulations more realistic than ever
Patient simulations have been a key tool for educating physicians in some form for hundreds of years – and now cutting-edge technologies are helping them […]
COVID-19 drives a new era of self-care
New research shows that the COVID-19 pandemic is encouraging people to take their health into their own hands, and experts say this trend towards self-care […]
Cutting through the noise for HCPs
In a world producing more content than ever before, getting information to time-poor HCPs can be incredibly difficult – even if they want to find […]
Predicting pandemics with unconventional digital tools
The world is awash with data, and while retailers and TV subscription services have perfected the art of collection and curation, public health has been […]
COVID-19’s lasting impact on digital communication in healthcare
The ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic. In The Medscape Professional Networks’ latest white […]
COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts
Despite the UK’s world class research output and the many start-ups successfully spinning out from its academic institutions, in recent years UK biotech companies have […]
Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast
Alnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route […]
Time for a health innovation pact: rethinking the design and delivery of healthcare
Janssen’s Anouk De Vroey on why we need to extend the public/private partnerships resulting from COVID-19 into more high-level dialogue on health innovation with governments. […]
Behind the scenes of the new ABPI Code of Practice
For over 60 years the ABPI Code of Practice has been key to the UK industry’s self-regulation, and now, as pharma is experiencing its most […]
Sharing oncology trial PROs to build the treatment of the future
Could collecting, understanding, and disseminating patient-reported outcomes during trials be the key to advancing oncology treatments and improving cancer outcomes? With our understanding of cancer […]
Coronavirus pharma news round-up 21/08/20
New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the […]
Why the next blockbuster in mental health might be a video game
David Keene looks at the difficulties faced in treating mental health patients and how digital technologies are changing the game. In 1919 a young Dwight […]
NHS’ telemedicine ambitions approach a pivotal point
The UK government has said it is vital to adopt telemedicine across the NHS in response to COVID-19 – but is the health service ready […]
Pharma improves HCP engagement during COVID-19 – report
Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted […]
What can pharma marketing learn from other regulated industries?
The financial world, like the pharmaceutical industry, must operate within a tightly-defined regulatory environment, and in doing so has proved adept at connecting with its […]
Coronavirus pharma news roundup – 14/08/20
Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories. Consumer advocacy group Public Citizen has […]
Emotional empathy is driving brand equity
How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Day by day it becomes clearer that some brands are coming through the pandemic […]
Bad behaviour: why understanding human behaviour can improve outcomes
Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour. Only […]
Coronavirus pharma news roundup – 07/08/20
Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Find out more in our roundup of […]
Post-viral syndrome: Learning to live with COVID-19 on the NHS
Recent months have exacerbated many of the issues that were facing the NHS before anyone had ever heard the word COVID-19 – and the scars […]
Tackling multimorbidity through collaboration
As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems. A new action group from the ABPI seeks to bring the NHS, academia […]
How does HTA for orphan drugs differ across europe?
New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always […]
Preparing for an influx of cell and gene therapy approvals
Cell and gene therapies offer some of the most groundbreaking advancements in patient care the pharma industry has ever seen. However, to fully realise the […]
Coronavirus pharma news roundup – 31/07/20
Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues. Here […]
The acceleration of pharma’s digital transformation
From this summer’s vantage point 2019 seems like it was at least a decade ago, such is the trainwreck that is 2020. But for pharma’s […]
Novartis, company culture and COVID-19: the pharmaphorum podcast
Novartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face of company culture, now and in the […]
Next wave: how pharma analytics can be improved with new technologies
Pharmaceutical companies have always had access to a steady stream of data to look at what has happened in the past and to try to […]
Brits more comfortable sharing data with pharma since COVID-19 – survey
New research from MHP Health and ComRes looks at what impacts COVID-19 has had on the public’s health data sharing concerns, and asks how the […]
Country focus: Iraq’s pharma industry sees upward trajectory
After decades of turmoil, Iraq’s healthcare sector is growing fast – but the country still holds some unique challenges for companies looking to enter its […]
GSK’s John Fleming on rethinking oncology from the ground up
What if we could look at cancer treatment from a completely fresh perspective? This is the philosophy GSK’s UK country medical head for oncology, John […]
Coronavirus pharma news roundup – 24/07/20
With coronavirus vaccine trials finally showing positive results, analysts are starting to wonder what access challenges might lie ahead. We highlight the top R&D, digital […]
How modular content provides ‘light-speed’ review and boosts engagement
Twenty-first century communications are fast, personalised and multi-channel – all of which can seem diametrically opposed to the heavily-regulated world of the pharmaceutical industry. But […]
MSD’s David Peacock on moving UK healthcare forward
David Peacock has worked across the world for MSD and other companies, and has now taken the helm of MSD’s UK & Ireland operations. In […]
Commercialising innovative new medicines
As pharmaceutical ingenuity hits new heights, ensuring that patients gain access to innovative medicines requires a unique combination of evidence generation and communication Working with […]
The enduring innovation and behaviour changes from COVID-19
The COVID-19 crisis has accelerated the shift to a more resilient, agile and innovative digitally-enabled world within healthcare and pharma. But the best companies are […]
Alnylam’s Anant Murthy on making it as a US biotech in Europe
Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the […]
How to increase haematologists’ and oncologists’ confidence with new treatments
A new whitepaper from Medscape highlights the difficulties haematologists and oncologists face in keeping up with rapid developments in treatment. We speak to the company’s […]
Coronavirus pharma news roundup – 17/07/20
Coronavirus vaccine trials continue – but experts warn that it’s too early to get hopes up. Meanwhile, the rise in digital health looks like it’s […]
Clinical decision support tools will help oncologists manage complexity
Making treatment decisions is a tough choice for oncologists: a therapy might save or significantly extend one patient’s life but not deliver the desired outcome […]
ICMRA seeks international alignment on COVID-19 product assessment
COVID-19 drugs, vaccines and diagnostics that are developed and tested within new international guidelines can expect rapid assessment and authorisation. The criteria, set out in […]
